Author:
Rowe Steven P.,Pienta Kenneth J.,Pomper Martin G.,Gorin Michael A.
Reference11 articles.
1. Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer;Cho;J Nucl Med,2012
2. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2012
3. “Gotta catch ‘em all”, or do we? Pokemet approach to metastatic prostate cancer;Murphy;Eur Urol,2017
4. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging;Sheikhbahaei;Eur J Nucl Med Mol Imaging,2017
5. PI-RADS Prostate Imaging-Reporting and Data System: 2015, version 2;Weinreb;Eur Urol,2016
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献